- Date : 28/06/2023
- Read: 3 mins
Want to unlock the power of healthcare investments? Discover if Quant MF's new fund is the game-changing opportunity you've been waiting for.
- Quant Healthcare Fund: Tap into healthcare potential.
- Open for subscription: June 27 - July 11, 2023.
- Benchmark: S&P BSE Healthcare TRI
- No entry or exit charges for investors
Are you looking to invest in the healthcare sector? Exciting news awaits as Quant Mutual Fund introduces their latest offering, the Quant Healthcare Fund. This open-ended equity scheme is specifically designed to tap into the vast potential of the healthcare sector. With the scheme now open for public subscription, investors have the opportunity to seize a stake in this promising venture. Act fast, as the subscription window is open from June 27, 2023, until July 11, 2023. Following the initial subscription period, the scheme will continue to be available for sale and repurchase within five business days from the date of allotment. In this mutual fund review, we delve into the details of the Quant Healthcare Fund and help you decide if this investment opportunity is the right fit for you.
Introduction to Quant Mutual Fund
Quant Mutual Fund, with AUM of Rs 18,500 crore, launched its second sectoral fund, Quant Healthcare Fund, within a week of launching Quant BFSI Fund. This is in line with the fund house's plan to launch multiple funds based on their in-house business cycle analytics.
Important features of the scheme are mentioned below:
- Minimum 80% of the scheme's investments will be allocated to healthcare, life sciences, insurance, and wellness companies such as pharmaceuticals, biotech, hospitals, medical devices, and more.
- The scheme will follow the S&P BSE Healthcare TRI as its benchmark and aim to optimise risk-return payoffs by investing across different market capitalizations.
- Utilising the VLRT framework i.e valuation, liquidity, risk appetite, and time, and predictive analytics tools, the fund house will actively manage known risks and identify opportunities within the portfolio.
- The scheme will be managed by Tandon, Pande, Sharma, and Sahgal, serving as the fund managers.
Does this scheme have any entry or exit charges?
There are zero entry and exit charges for investors in this scheme.
What is the future of the Pharma sector?
The Indian pharmaceutical sector shows great promise, with the medical tourism market projected to grow from $2.89 billion in 2020 to $13.42 billion by 2026. Indian pharmaceutical companies are well-positioned to capitalise on global opportunities due to their competitiveness and significant market share. While long-term returns for pharma funds are lower compared to sectors like technology and banking, short-term returns have been impressive, with 7.04% (one-month) and 15.44% (three-month) returns.
The Quant Healthcare Fund targets the healthcare sector, presenting notable advantages such as its alignment with a thriving industry and zero entry and exit charges. However, it is important to note that the fund carries a high-risk profile. It is important for investors to do their own research before investing. This includes understanding the risks involved, the potential returns, and the overall investment strategy.
This article is intended for general information purposes only and should not be construed as investment or tax advice.
Click here for the latest articles on Mutual Funds